Business Wire

PSE

Share
Process Systems Enterprise: APM Forum 2019 focus on digitalisation for the process industries

Digital design and digital operations were the key focus at the 2019 Advanced Process Modelling (APM) Forum in London, where leading process industry organisations presented on how advanced modelling technologies are helping to create value in applications ranging from accelerating time-to-market of new pharmaceuticals to maximising production from multiple oil & gas processing sites simultaneously.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190403005719/en/

Introducing the event, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), said that technologies that combine prior knowledge, in the form of physics-based models, with laboratory or plant data, or use accurate nonlinear surrogate models derived from large-scale physics-based models, now provide unprecedented opportunities for exploring the design decision space and incorporating deep process knowledge in operational decision systems.

Keynote speaker Bob Docherty, Strategic Lead for Digital Design at Pfizer, presented a global vision for digitalisation in the pharma industry that enables a level of clarity in manufacturing processes never available before. Mathias Oppelt, head of simulation at Siemens, described how Siemens is bringing to market intelligent digital operations tools, capable of generating value daily, that incorporate high-fidelity process models using PSE’s gPROMS technology, as well as integrated engineering systems capable of generating process digital twins automatically during the engineering phase.

In the Formulated Products track, presenters from GSK, Pfizer, Eli Lilly, AstraZeneca, BMS, UCB and Novo Nordisk described a range of applications built on PSE’s gPROMS FormulatedProducts modelling environment: end-to-end digital design applications to enhance drug substance and drug product R&D and manufacture, the increasing application of mechanistic models in manufacturing for control scheme development, process monitoring and soft-sensing, and the use of digital twins for optimising fermentation processes. PSE and Centre of Excellence partners NIZO launched the new gPROMS Food capability for modelling food products and processes.

In the Energy & Chemicals track, integrated petrochemicals manufacturer SCG Chemicals described the use of digital twins for rapid-response operator decision support for their vinyl chloride monomer (VCM) operations. DNV GL showed their COSSMOS digital design environment for integrated ship systems, and RWTH Aachen described how optimisation technology now enables simultaneous design of process, equipment and working fluid in organic Rankine cycles and CO2 absorption processes. Siemens demonstrated a digital twin for integrated wells-to-facilities optimisation of oilfield production embedded in a Siemens XHQ dashboard, for operations room decision support.

PSE launched major new capabilities including enhanced digital design capabilities in the forthcoming gPROMS 6 modelling platform, where high-performance computing (HPC) capabilities now enable execution of complex models on massively parallel clusters to allow rapid and effective exploration of large decision spaces, and gPROMS Properties, PSE’s new properties and advanced thermodynamics platform. The new gPROMS Digital Applications Platform for building, testing and deploying robust and efficient digital applications within plant automation or management systems was demonstrated using a nonlinear model predictive controller for polymer production. Also announced were the new gPROMS Web Applications System for delivering models to ‘non-modelling’ users across the organisation via web interfaces, and the new gPROMS ProcessBuilder which allows seamless workflows from steady-state to dynamic modelling within the same environment.

Says Pantelides, “several strands of core technology are now coming together to accelerate digital design and to bring exciting new capabilities to operations. High-fidelity process models are at the heart of this. It’s all moving very rapidly”.

Contact:

Kate Burness +44-20-8563-0888 k.burness@psenterprise.com Editors: www.psenterprise.com/news/pr190403

Link:

ClickThru

Social Media:

https://www.facebook.com//Process-Systems-Enterprise-Limited-PSE-194030330653358/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release

Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc

Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye